Business context and reporting period
The Scotts Miracle-Gro Company filed this Form 10-K for the fiscal year ended September 30, 2023. The company sells consumer lawn and garden products through U.S. Consumer and Other (primarily Canada), and indoor and hydroponic gardening products through Hawthorne. Its business is seasonal, with about 75% of North American consumer lawn and garden sales typically occurring in the second and third fiscal quarters.
Financial performance and liquidity
| Metric | FY2023 | FY2022 |
|---|---|---|
| Net sales | $3,551.3 million | $3,924.1 million |
| Gross margin | $657.3 million; 18.5% | $872.9 million; 22.2% |
| Operating income (loss) | $(174.4) million | $(434.0) million |
| Net income (loss) | $(380.1) million; diluted EPS $(6.79) | $(437.5) million; diluted EPS $(7.88) |
| Cash from operations | $531.0 million | $(129.0) million |
| Free cash flow (non-GAAP) | $438.2 million | $(242.5) million |
| Adjusted EBITDA (non-GAAP) | $446.9 million | $557.9 million |
At year-end, cash was $31.9 million and total debt was $2,630.6 million, versus $86.8 million and $2,992.1 million, respectively, a year earlier. Borrowing availability under the credit agreement was $1,156.7 million. Stockholders’ equity was a deficit of $267.3 million. Fiscal 2023 interest expense rose 50.8% to $178.1 million; the weighted-average rate on credit facility borrowings, excluding swaps, was 7.6% versus 2.8%.
Material changes versus the prior year
- Sales fell 9.5%; lower volume and mix reduced sales 14.3%, partly offset by 5.0% pricing. Volume declines affected all segments.
- U.S. Consumer sales declined 2.9% to $2,843.7 million and segment profit fell 20.1% to $454.1 million. Hawthorne sales declined 34.8% to $467.3 million and its segment loss widened to $48.1 million. Other sales fell 13.9% to $240.3 million.
- Gross margin rate declined 3.7 percentage points, reflecting material and labor costs, lower volume and fixed-cost under-absorption, inventory write-downs and restructuring charges; price increases and lower warehousing costs partly offset these pressures.
- Cash from operations improved by $660.0 million, principally due to inventory reduction, lower incentive payouts and tax refunds. Inventory declined to $880.3 million from $1,343.5 million.
- Net debt repayments were $353.6 million. The company paid $149.1 million in dividends and had no active share repurchase program at year-end.
Outlook, management commentary, risks and unusual items
- The company expects its restructuring program to produce at least $300 million in annualized run-rate savings, nearly all by the end of FY2024. It incurred $229.0 million of related costs in FY2023 and $294.1 million cumulatively since inception; further restructuring charges remain possible. Management expects FY2024 capital expenditures to be generally consistent with recent spending.
- Management said inflation, volatile commodity costs and higher interest rates were expected to persist. Hawthorne remains exposed to cannabis-market oversupply and weaker cultivation activity; management cautioned that a longer or more severe downturn could further harm results. No specific FY2024 revenue or earnings guidance is provided in the filing text.
- FY2023 included $466.1 million of impairment, restructuring and other charges, including a $117.7 million Hawthorne intangible-asset impairment, a $101.3 million impairment of convertible debt investments, and a $94.7 million impairment of the Bonnie Plants investment. These items substantially affected GAAP results.
- After an earnings shortfall, the company amended its credit agreement in July 2023. Changes included reduced revolving commitments, higher borrowing costs, additional collateral including intellectual property, and restrictions on dividends and certain investments. The leverage ratio was 6.57 against a 7.75 maximum for FY2023 Q4; the company reported covenant compliance at year-end and expected to remain compliant over the following 12 months. Limits tighten over time. Management warned that a default could accelerate debt and that available liquidity would not be sufficient to repay the relevant outstanding debt in that event.
- Credit ratings were downgraded by S&P and Moody’s in August 2023. Home Depot and Lowe’s represented 47% of FY2023 sales and 41% of year-end receivables. Other significant risks include weather, raw-material costs, regulation, product liability, and the Roundup marketing agreement.
- The company reported an unqualified audit opinion and effective internal control over financial reporting. The auditor identified Hawthorne intangible-asset impairment and the Bonnie Plants investment impairment as critical audit matters.
Important facts for investors to verify
- Whether restructuring savings materialize on schedule and translate into improved margins and cash generation.
- Hawthorne demand, cannabis-market conditions, and the assumptions behind impairment valuations and convertible-debt investment recoverability.
- Quarterly covenant headroom as permitted leverage thresholds tighten, and the company’s refinancing and liquidity options.
- Whether pricing can offset inflation without worsening volume, and whether seasonal inventory and working-capital needs remain manageable.
- Exposure to major retail customers, the Roundup agreement’s continuation and economics, and any material developments in environmental or product-related proceedings.